Pages that link to "Q31122398"

The following pages link to The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations (Q31122398):

Displaying 46 items.

• Palmitoylethanolamide induces microglia changes associated with increased migration and phagocytic activity: involvement of the CB2 receptor (Q33671206) (← links)
• A novel composite formulation of palmitoylethanolamide and quercetin decreases inflammation and relieves pain in inflammatory and osteoarthritic pain models (Q38646217) (← links)
• Cannabimimetic phytochemicals in the diet - an evolutionary link to food selection and metabolic stress adaptation? (Q39021787) (← links)
• Palmitoylethanolamide Modulates GPR55 Receptor Signaling in the Ventral Hippocampus to Regulate Mesolimbic Dopamine Activity, Social Interaction, and Memory Processing (Q41152448) (← links)
• Expression and Differential Responsiveness of Central Nervous System Glial Cell Populations to the Acute Phase Protein Serum Amyloid A. (Q42030450) (← links)
• 2-Pentadecyl-2-Oxazoline, the Oxazoline of Pea, Modulates Carrageenan-Induced Acute Inflammation (Q42239212) (← links)
• Palmitic Acid: Physiological Role, Metabolism and Nutritional Implications. (Q46799280) (← links)
• Palmitoylethanolamide Supplementation during Sensitization Prevents Airway Allergic Symptoms in the Mouse (Q47222146) (← links)
• Palmitoylethanolamide Blunts Amyloid-β42-Induced Astrocyte Activation and Improves Neuronal Survival in Primary Mouse Cortical Astrocyte-Neuron Co-Cultures (Q47962439) (← links)
• Ultramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer's disease by exerting anti-inflammatory and neuroprotective effects (Q48139053) (← links)
• Ultramicronized palmitoylethanolamide counteracts the effects of compound 48/80 in a canine skin organ culture model. (Q48323713) (← links)
• An Inflammation-Centric View of Neurological Disease: Beyond the Neuron (Q52331711) (← links)
• Palmitoylethanolamide Ameliorates Hippocampal Damage and Behavioral Dysfunction After Perinatal Asphyxia in the Immature Rat Brain (Q52584461) (← links)
• Oral Ultramicronized Palmitoylethanolamide: Plasma and Tissue Levels and Spinal Anti-hyperalgesic Effect. (Q52608759) (← links)
• Palmitoylethanolamide Dampens Reactive Astrogliosis and Improves Neuronal Trophic Support in a Triple Transgenic Model of Alzheimer's Disease: In Vitro and In Vivo Evidence. (Q52632555) (← links)
• Principles of pharmacological research of nutraceuticals. (Q55072787) (← links)
• Localization of cannabinoid receptors CB1, CB2, GPR55, and PPARα in the canine gastrointestinal tract (Q56379613) (← links)
• Endocannabinoids and related -acylethanolamines: biological activities and metabolism (Q57055931) (← links)
• New approaches and challenges to targeting the endocannabinoid system (Q57165498) (← links)
• Efficacy of ultramicronized palmitoylethanolamide in burning mouth syndrome-affected patients: a preliminary randomized double-blind controlled trial (Q58554395) (← links)
• On the Viability and Potential Value of Stem Cells for Repair and Treatment of Central Neurotrauma: Overview and Speculations (Q58785850) (← links)
• Biomarkers for PTSD at the Interface of the Endocannabinoid and Neurosteroid Axis (Q58798790) (← links)
• Prophylactic Palmitoylethanolamide Prolongs Survival and Decreases Detrimental Inflammation in Aged Mice With Bacterial Meningitis (Q59798181) (← links)
• The prefrontal cortical endocannabinoid system modulates fear-pain interactions in a subregion-specific manner (Q60680360) (← links)
• Palmitoylethanolamide prevents neuroinflammation, reduces astrogliosis and preserves recognition and spatial memory following induction of neonatal anoxia-ischemia (Q60714197) (← links)
• Clinical applications of palmitoylethanolamide in pain management: protocol for a scoping review (Q60918045) (← links)
• Biomarkers of response to alpha-lipoic acid ± palmitoiletanolamide treatment in patients with diabetes and symptoms of peripheral neuropathy. (Q64935458) (← links)
• Non-endocannabinoid N-acylethanolamines and 2-monoacylglycerols in the intestine (Q87859320) (← links)
• Chronic Oral Palmitoylethanolamide Administration Rescues Cognitive Deficit and Reduces Neuroinflammation, Oxidative Stress, and Glutamate Levels in A Transgenic Murine Model of Alzheimer's Disease (Q89598869) (← links)
• The Effect of Orally Dosed Levagen ™ (palmitoylethanolamide) on Exercise Recovery in Healthy Males-A Double-Blind, Randomized, Placebo-Controlled Study (Q89920458) (← links)
• Is There a Future for PPARs in the Treatment of Neuropsychiatric Disorders? (Q89976057) (← links)
• Therapeutic Efficacy of Palmitoylethanolamide and Its New Formulations in Synergy with Different Antioxidant Molecules Present in Diets (Q90079410) (← links)
• An Update of Palmitoylethanolamide and Luteolin Effects in Preclinical and Clinical Studies of Neuroinflammatory Events (Q90162519) (← links)
• Cellular Distribution of Canonical and Putative Cannabinoid Receptors in Canine Cervical Dorsal Root Ganglia (Q90682483) (← links)
• Micronized Palmitoylethanolamide: A Post Hoc Analysis of a Controlled Study in Patients with Low Back Pain - Sciatica (Q91589815) (← links)
• Review of Clinical Studies Targeting Inflammatory Pathways for Individuals With Autism (Q91867592) (← links)
• Cannabinoids and the expanded endocannabinoid system in neurological disorders (Q91934280) (← links)
• Palmitoylethanolamide counteracts substance P-induced mast cell activation in vitro by stimulating diacylglycerol lipase activity (Q92263433) (← links)
• Palmitoylethanolamide (PEA) as a Potential Therapeutic Agent in Alzheimer's Disease (Q92510517) (← links)
• Molecular Targets of Fatty Acid Ethanolamides in Asthma (Q92795215) (← links)
• Partial Reversal of Striatal Damage by Palmitoylethanolamide Administration Following Perinatal Asphyxia (Q92861460) (← links)
• A co-ultramicronized palmitoylethanolamide/luteolin composite mitigates clinical score and disease-relevant molecular markers in a mouse model of experimental autoimmune encephalomyelitis (Q92912268) (← links)
• Effect of dietary supplementation with ultramicronized palmitoylethanolamide in maintaining remission in cats with nonflea hypersensitivity dermatitis: a double-blind, multicentre, randomized, placebo-controlled study (Q93008031) (← links)
• Broad Lipidomic and Transcriptional Changes of Prophylactic PEA Administration in Adult Mice (Q93061174) (← links)
• Peroxisome Proliferator-Activated Receptors as a Therapeutic Target in Asthma (Q94569758) (← links)
• Tolerability of Palmitoylethanolamide in a Pediatric Population Suffering from Migraine: A Pilot Study (Q94863334) (← links)